Citação norma APA

Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., . . . Roudaut, M. (2015). Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective. BMC Health Serv Res.

Citação norma Chicago

Charokopou, M., P. McEwan, S. Lister, L. Callan, K. Bergenheim, K. Tolley, R. Postema, R. Townsend, and M. Roudaut. "Cost-effectiveness of Dapagliflozin Versus DPP-4 Inhibitors As an Add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus From a UK Healthcare System Perspective." BMC Health Serv Res 2015.

Citação norma MLA

Charokopou, M., et al. "Cost-effectiveness of Dapagliflozin Versus DPP-4 Inhibitors As an Add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus From a UK Healthcare System Perspective." BMC Health Serv Res 2015.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.